Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 128Breast Neoplasms 95Colorectal Neoplasms 62Carcinoma, Hepatocellular 59Stomach Neoplasms 49Squamous Cell Carcinoma of Head and Neck 47Lung Neoplasms 44Prostatic Neoplasms 43Leukemia, Myeloid, Acute 43Triple Negative Breast Neoplasms 42Small Cell Lung Carcinoma 40Uterine Cervical Neoplasms 37Rectal Neoplasms 36Pancreatic Neoplasms 31Neoplasms 29Neoplasm Metastasis 29Recurrence 26Esophageal Squamous Cell Carcinoma 25Ovarian Neoplasms 23Esophageal Neoplasms 23Nasopharyngeal Carcinoma 21Brain Neoplasms 21Lymphoma, Large B-Cell, Diffuse 20Colonic Neoplasms 20Carcinoma, Renal Cell 20Melanoma 19Endometrial Neoplasms 19Biliary Tract Neoplasms 18Head and Neck Neoplasms 17Multiple Myeloma 16

Interventions

Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Nevus × Clear all
NCT07477548 2026-03-17

A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies

Yonsei University

Phase 2 Not yet recruiting
67 enrolled

Arteriovenous Malformations, Hemangioendothelioma, Hemangioma, Lymphangioma, Nevus, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡